KZRInvestor•businesswire•
Kezar Life Sciences to Participate in Two Upcoming Investor Conferences
Sentiment:Negative (15)
Summary
(NASDAQ:KZR) SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that Chris Kirk, Chief Executive Officer and Co-founder, will participate in two upcoming investor conferences taking place in September: Event: 2025 Wells Fargo Healthcare Conference Location: Boston, MA Date/Time: Friday, September 5, 2025, at 11:00 am ET Form
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 28, 2025 by businesswire